Company intelligence / Profile preview

Scan Aqua AS

Hvam, Norway

Ownership: Private
Development stage: Other

Overview

Scan Aqua AS developed and sold Rx pharmaceuticals for fish health, including sedatives and anesthetics for aquaculture. Acquired by MSD Animal Health (Merck Animal Health) in March 2019; products integrated into acquirer's portfolio.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Veterinary

Beyond the preview

Go deeper on Scan Aqua AS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scan Aqua AS.

Explore the full profile